BUILDING BIOLOGY Codex DNA presentation | February 2022 SAFE HARBOR STATEMENTS The information contained in this presentation has been made available to you with the consent of Codex DNA ("Codex DNA," the "Company," "we" or "our") for informational purposes only. This presentation is strictly confidential and may not be reproduced or redistributed in whole or in part nor may its contents be disclosed to any other person without our prior written permission. By viewing this presentation, you agree to keep an ...

Codex DNA, Inc. (DNAY) Q3 2021 Earnings Conference Call November 9, 2021 5:00 AM ET Company Participants Richard Lepke - Director of IR Todd Nelson - CEO Jennifer McNealey - CFO Dan Gibson - Chief Technology Officer Conference Call Participants Brandon Couillard - Jefferies Operator Ladies and gentlemen, thank you for standing by and welcome to the Quarter 3 2021 Codex DNA Inc. Earnings Conference Call. At this time, all participantsÂ' lines are in a listen-only mode. Later, we will conduct a question-and-a ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _____________ Commission file number 001-40497 CODEX DNA, INC. (Exact name of registrant as specified in its charter) Del ...

For the transition period from ___________ to _____________ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-40497 CODEX DNA, INC. (Exact name of registrant as specified in its charter) Delaware ...

Codex DNA, Inc. (DNAY) Q2 2021 Earnings Conference Call August 10, 2021 5:00 PM ET Company Participants Jennifer McNealey - Chief Financial Officer Todd Nelson - Chief Executive Officer Dan Gibson - Chief Technology Officer Conference Call Participants Paul Knight - KeyBanc Brandon Couillard - Jefferies Operator Good day. And thank you for standing by. Welcome to the Second Quarter 2021 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there ...